CHR Citadelle Liège

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Heart failure1 trial
• IgA nephropathy1 trial
• Kidney cancer1 trial
• Multiple myeloma1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• AZ Sint-Jan AV1 trial
• Celgene1 trial
• Ipsen1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• University Hospital, Antwerp1 trial

Running trials

• Active, not recruiting

  Left Bundle Branch Area Pacing Using Conventional Stylet-driven Pacemaker Leads for Cardiac Resynchronization Therapy

  NCT05365568· AZ Sint-Jan AV· Source

• Recruiting

  Belgian Registry on Coronary Function Testing

  NCT06089031· University Hospital, Antwerp· Source

  Contact: Charles Pirlet, MD

• Active, not recruiting

  Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

  NCT04106349· Ipsen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting

Closed trials

• Active, not recruiting

  Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

  NCT05248646· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Completed

  A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

  NCT03106324· Celgene· Source